A series by Chalkiadakis et al. reported that 31% had liver metastases, 29% had metastases to the mediastinum, 18% had metastases to the lungs and 13% had metastases to the brain at the time of diagnosis 14.
Chalkiadakis y sus investigadores, 14 en su serie identificaron 31% de metástasis hepáticas, 29% al mediastino, 18% al pulmón y 13% al cerebro, al momento del diagnóstico.